戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  and VMAT2, and by carbidopa, which inhibits aromatic L-amino acid decarboxylase.
2 t decrement in tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AAAD) activities.
3 functional recovery mechanisms, with reduced aromatic L-amino acid decarboxylase (AAAD) activity clos
4                                              Aromatic L-amino acid decarboxylase (AAAD) and tyrosine
5                                          The aromatic L-amino acid decarboxylase (AAAD) is involved i
6 st cells (PF) were genetically modified with aromatic L-amino acid decarboxylase (AADC) and VMAT-2 ge
7                                              Aromatic l-amino acid decarboxylase (AADC) deficiency is
8                                              Aromatic l-amino acid decarboxylase (AADC) deficiency is
9                                      The rat aromatic l-amino acid decarboxylase (AADC) gene contains
10                  Homozygous mutations in the aromatic l-amino acid decarboxylase (AADC) gene result i
11  and non-NMDA antagonists on the activity of aromatic l-amino acid decarboxylase (AADC) in the corpus
12  techniques that cells containing the enzyme aromatic l-amino acid decarboxylase (AADC) occur not onl
13 ted whether the downregulation of the enzyme aromatic l-amino acid decarboxylase (AADC) or the TH cof
14 F110 up-regulates tyrosine hydroxylase (TH), aromatic l-amino acid decarboxylase (AADC), and GTP cycl
15 atic l-amino acids may also be substrates of aromatic l-amino acid decarboxylase (AADC), the level of
16 ericytes that ectopically express the enzyme aromatic L-amino acid decarboxylase (AADC), which synthe
17                                          The aromatic L-amino-acid decarboxylase (AADC) defect appear
18    Alveolar Type II cells express the enzyme aromatic-L-amino acid decarboxylase (AADC) and, when inc
19                                              Aromatic L-amino acid decarboxylases (AADCs) are key enz
20 urine analyses indicated reduced activity of aromatic L-amino acid decarboxylase and other PLP-depend
21  1 in immature neurons and the expression of aromatic l-amino acid decarboxylase and tyrosine hydroxy
22 nces upstream of the C.elegans gene encoding aromatic L-amino-acid decarboxylase and genes involved i
23 ween these two epithelial lineages), and (c) aromatic l-amino-acid decarboxylase, but not its dopamin
24 1) devised a novel in-house assay for PGD of aromatic L-amino acid decarboxylase deficiency, based on
25 howed the clinical phenotype to be caused by aromatic L-amino acid decarboxylase deficiency.
26  dopaminergic markers, tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine, 3,4-dihyd
27 ssion tomography (PET) imaging agent for the aromatic L-amino acid decarboxylase enzyme.
28 rmal growth factor-induced proliferation, or aromatic L-amino acid decarboxylase expression.
29 nin transporter, tryptophan hydroxylase, and aromatic L-amino acid decarboxylase genes whose expressi
30 inflammation by inducing vagal activation of aromatic L-amino acid decarboxylase, leading to the prod
31 tudied in PC12 cells following inhibition of aromatic L-amino acid decarboxylase with m-hydroxybenzyl

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。